The biological pathways of Alzheimer disease: a review

被引：146
作者：
Calabro, Marco [1 ]
Rinaldi, Carmela [1 ]
Santoro, Giuseppe [1 ]
Crisafulli, Concetta [1 ]
机构：
[1] Univ Messina, Dept Biomed & Dent Sci & Morphofunct Imaging, Messina, Italy
来源：
AIMS NEUROSCIENCE | 2021年 / 8卷 / 01期
关键词：
Alzheimer disease; biological pathways; immune system; oxidative stress; AMYLOID-BETA-PEPTIDE; GENOME-WIDE ASSOCIATION; BRAIN INSULIN-RESISTANCE; LONG-TERM POTENTIATION; APOLIPOPROTEIN-E; A-BETA; OXIDATIVE STRESS; COGNITIVE IMPAIRMENT; CEREBRAL HYPOPERFUSION; DIAGNOSTIC GUIDELINES;
D O I：
10.3934/Neuroscience.2021005
中图分类号：
Q189 [神经科学];
学科分类号：
071006 ;
摘要：
Alzheimer disease is a progressive neurodegenerative disorder, mainly affecting older people, which severely impairs patients' quality of life. In the recent years, the number of affected individuals has seen a rapid increase. It is estimated that up to 107 million subjects will be affected by 2050 worldwide. Research in this area has revealed a lot about the biological and environmental underpinnings of Alzheimer, especially its correlation with beta-Amyloid and Tau related mechanics; however, the precise molecular events and biological pathways behind the disease are yet to be discovered. In this review, we focus our attention on the biological mechanics that may lie behind Alzheimer development. In particular, we briefly describe the genetic elements and discuss about specific biological processes potentially associated with the disease.
引用
收藏
页码：86 / 132
页数：47
相关论文
共 424 条
  • [101] The Vascular Hypothesis of Alzheimer's Disease: A Key to Preclinical Prediction of Dementia Using Neuroimaging
    de la Torre, Jack
    [J]. JOURNAL OF ALZHEIMERS DISEASE, 2018, 63 (01) : 35 - 52
  • [102] de la Torre Jack C, 2012, Cardiovasc Psychiatry Neurol, V2012, P367516, DOI 10.1155/2012/367516
  • [103] The secretases: enzymes with therapeutic potential in Alzheimer disease
    De Strooper, Bart
    Vassar, Robert
    Golde, Todd
    [J]. NATURE REVIEWS NEUROLOGY, 2010, 6 (02) : 99 - 107
  • [104] Ryanodine receptors: physiological function and deregulation in Alzheimer disease
    Del Prete, Dolores
    Checler, Frederic
    Chami, Mounia
    [J]. MOLECULAR NEURODEGENERATION, 2014, 9
  • [105] The prevalence of CD33 and MS4A6A variant in Chinese Han population with Alzheimer's disease
    Deng, Yu-Lei
    Liu, Li-Hua
    Wang, Ying
    Tang, Hui-Dong
    Ren, Ru-Jing
    Xu, Wei
    Ma, Jian-Fang
    Wang, Li-Ling
    Zhuang, Jun-Peng
    Wang, Gang
    Chen, Sheng-Di
    [J]. HUMAN GENETICS, 2012, 131 (07) : 1245 - 1249
  • [106] Viral Hypothesis and Antiviral Treatment in Alzheimer's Disease
    Devanand, D. P.
    [J]. CURRENT NEUROLOGY AND NEUROSCIENCE REPORTS, 2018, 18 (09)
  • [107] Protein Homeostasis Networks and the Use of Yeast to Guide Interventions in Alzheimer's Disease
    Dhakal, Sudip
    Macreadie, Ian
    [J]. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2020, 21 (21) : 1 - 45
  • [108] The Cell Biology of the Unfolded Protein Response
    Diehl, J. Alan
    Fuchs, Serge Y.
    Koumenis, Costantinos
    [J]. GASTROENTEROLOGY, 2011, 141 (01) : 38 - U109
  • [109] Contribution of metabolic syndrome components to cognition in older individuals
    Dik, Miranda G.
    Jonker, Cees
    Comijs, Hannie C.
    Deeg, Dorly J. H.
    Kok, Astrid
    Yaffe, Kristine
    Penninx, Brenda W.
    [J]. DIABETES CARE, 2007, 30 (10) : 2655 - 2660
  • [110] Neutral Sphingomyelinase-2 Deficiency Ameliorates Alzheimer's Disease Pathology and Improves Cognition in the 5XFAD Mouse
    Dinkins, Michael B.
    Enasko, John
    Hernandez, Caterina
    Wang, Guanghu
    Kong, Jina
    Helwa, Inas
    Liu, Yutao
    Terry, Alvin V., Jr.
    Bieberich, Erhard
    [J]. JOURNAL OF NEUROSCIENCE, 2016, 36 (33) : 8653 - 8667
6789101112131415